ArticleTargeted oncology2017

Acquired Resistance to Erlotinib in EGFR Mutation-Positive Lung Adenocarcinoma among Hispanics (CLICaP).

Andrés F Cardona et al.PubMed ↗Publisher ↗

No numbers read from the abstract.